Markedly, the frequency of p53LOH increases as cancer progress: 52% of stage 1, but only 20% of stage 2 breast cancer patients retain wild type p53 (wtp53) allele [3], that suggests the strong selective pressure for p53LOH occurrence during tumor progression. Here, TP53 is linked to breast carcinoma.